Preventive Care Planning in Multimorbidity: A Comprehensive Review

Abstract

Multimorbidity, defined as the coexistence of two or more chronic conditions in an individual, presents significant challenges for preventive care. This review highlights the epidemiological burden, underlying pathophysiology, associated risk factors, clinical features, diagnostic considerations, and management strategies for preventive care in multimorbid populations. Emphasis is placed on guideline-based, patient-centered, and multidisciplinary approaches, with a focus on recent advances and emerging therapies. The article aims to equip healthcare professionals with actionable insights to optimize outcomes in this complex patient cohort.

Introduction

The rising prevalence of multimorbidity is transforming the landscape of clinical practice, particularly in primary care and geriatrics. Preventive care planning for patients with multiple chronic diseases requires an integrated, evidence-based approach to maximize health outcomes and minimize treatment burden. Multimorbidity complicates disease trajectories, increases polypharmacy risk, and challenges traditional single-disease guidelines. Hence, a nuanced understanding of the interplay between conditions and the impact on preventive interventions is critical for clinicians. This review synthesizes current evidence and practical strategies for effective preventive care in multimorbid patients, underscoring the importance of individualized care plans and shared decision-making.

Epidemiology / Disease Burden

Multimorbidity affects more than one in four adults globally, with prevalence rates exceeding 65% among those aged 65 and older. Epidemiological data from large cohort studies, such as the UK Biobank and NHANES, underscore a significant rise in multimorbidity over the past two decades, driven by aging populations and improved survival from chronic diseases. The burden of multimorbidity is associated with increased healthcare resource utilization, higher rates of unplanned hospitalizations, and greater mortality. Notably, socioeconomic deprivation, ethnic minority status, and lower educational attainment are linked to higher multimorbidity prevalence. The growing disease burden necessitates robust preventive strategies to curb complications and optimize resource allocation.

Pathophysiology

The pathophysiology of multimorbidity is multifactorial, involving complex interactions between genetic predisposition, environmental exposures, and lifestyle factors. Chronic systemic inflammation, neurohormonal dysregulation, and metabolic syndrome are common mechanistic pathways that underpin multiple coexisting diseases, such as cardiovascular disease, diabetes, and chronic kidney disease. Shared molecular mechanisms, such as oxidative stress and endothelial dysfunction, contribute to concurrent disease progression and amplify risk for adverse events. Understanding these interconnected pathways is essential for designing effective preventive interventions that target common underlying mechanisms rather than isolated disease processes.

Risk Factors

Key risk factors for multimorbidity include advanced age, sedentary lifestyle, obesity, smoking, excessive alcohol intake, and poor dietary habits. Genetic susceptibility and family history further increase risk, while psychosocial determinants such as social isolation, mental health disorders, and chronic stress are increasingly recognized contributors. Polypharmacy and inappropriate prescribing can exacerbate risk, particularly in older adults. Early identification of at-risk individuals through comprehensive risk assessment tools enables timely, targeted preventive care planning.

Clinical Features

Patients with multimorbidity often present with overlapping and non-specific symptoms, including fatigue, pain, cognitive impairment, and functional decline. The presence of multiple chronic conditions complicates symptom attribution and may mask acute illnesses. Furthermore, multimorbidity is associated with increased frailty, higher rates of depression and anxiety, and reduced quality of life. Clinicians must adopt a holistic approach to symptom assessment and prioritize interventions based on patient values and functional status.

Diagnosis

Diagnosing multimorbidity requires systematic evaluation using validated tools such as the Charlson Comorbidity Index and the Cumulative Illness Rating Scale. Comprehensive geriatric assessment is recommended for older adults, incorporating medical, psychological, and social domains. Laboratory and imaging investigations are guided by presenting symptoms and existing comorbidities, with attention to minimizing unnecessary testing and iatrogenic harm. Regular review of medication lists and adherence to deprescribing protocols are essential components of diagnostic assessment in multimorbid patients.

Treatment & Management

Effective management of multimorbidity centers on individualized care plans that integrate preventive, therapeutic, and supportive interventions. Key principles include shared decision-making, prioritization of patient goals, and minimization of treatment burden. Preventive strategies encompass immunizations, cancer screening, cardiovascular risk reduction, and falls prevention, tailored to life expectancy and functional capacity. Multidisciplinary team involvement is paramount, with coordinated input from primary care, pharmacy, nursing, and allied health professionals. Regular medication reviews, deprescribing where appropriate, and management of drug–drug interactions are critical to reducing polypharmacy risks. Patient education and self-management support further empower individuals to participate actively in their care.

Recent Advances / Emerging Therapies

Recent advances in preventive care for multimorbidity include digital health interventions, personalized risk prediction models, and integrated care pathways. The use of artificial intelligence and machine learning aids in risk stratification and early identification of high-risk patients. Pharmacogenomic testing offers promise in minimizing adverse drug reactions and optimizing polypharmacy management. Collaborative care models, such as the patient-centered medical home and chronic care model, have demonstrated efficacy in improving preventive care delivery and patient outcomes. Moreover, ongoing trials are investigating the utility of novel anti-inflammatory agents and senolytics in targeting shared disease mechanisms.

Guideline Recommendations

International guidelines from bodies such as the National Institute for Health and Care Excellence (NICE), American Geriatrics Society (AGS), and World Health Organization (WHO) emphasize patient-centered, goal-oriented care in multimorbidity. Key recommendations include regular medication reconciliation, deprescribing, prioritization of preventive interventions based on patient preferences, and multidisciplinary care coordination. Guidelines advocate for individualized cancer screening and chronic disease monitoring, considering life expectancy and comorbidity burden. The incorporation of frailty assessment and shared decision-making tools is strongly encouraged to enhance preventive care planning.

Conclusion

Preventive care planning in multimorbidity is a dynamic and complex process that necessitates a holistic, evidence-based, and patient-centered approach. The interplay of multiple chronic conditions requires clinicians to move beyond disease-specific paradigms and adopt strategies that address common pathophysiological pathways, modifiable risk factors, and patient priorities. Recent advances in digital health, pharmacogenomics, and integrated care models offer new avenues to optimize preventive care delivery. Adherence to guideline recommendations, multidisciplinary collaboration, and ongoing patient engagement are essential for improving outcomes and quality of life in this growing patient population.